Clearside Biomedical Statistics

Total Valuation

CLSD has a market cap or net worth of $70.02 million. The enterprise value is $102.65 million.

Market Cap	70.02M
Enterprise Value	102.65M

Important Dates

The last earnings date was Thursday, March 27, 2025, after market close.

Earnings Date	Mar 27, 2025
Ex-Dividend Date	n/a

Share Statistics

CLSD has 77.14 million shares outstanding. The number of shares has increased by 19.41% in one year.

Current Share Class	77.14M
Shares Outstanding	77.14M
Shares Change (YoY)	+19.41%
Shares Change (QoQ)	+1.48%
Owned by Insiders (%)	7.61%
Owned by Institutions (%)	15.18%
Float	69.97M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	40.71
Forward PS	172.06
PB Ratio	-1.81
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	61.69
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 4.44

Current Ratio	4.44
Quick Ratio	4.28
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-2.95

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-61.04%
Return on Invested Capital (ROIC)	-88.70%
Return on Capital Employed (ROCE)	-142.05%
Revenue Per Employee	$55,467
Profits Per Employee	-$1.15M
Employee Count	30
Asset Turnover	0.06
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -40.68% in the last 52 weeks. The beta is 2.01, so CLSD's price volatility has been higher than the market average.

Beta (5Y)	2.01
52-Week Price Change	-40.68%
50-Day Moving Average	0.96
200-Day Moving Average	1.07
Relative Strength Index (RSI)	44.13
Average Volume (20 Days)	199,726

Short Selling Information

The latest short interest is 735,552, so 0.95% of the outstanding shares have been sold short.

Short Interest	735,552
Short Previous Month	767,373
Short % of Shares Out	0.95%
Short % of Float	1.05%
Short Ratio (days to cover)	2.99

Income Statement

In the last 12 months, CLSD had revenue of $1.66 million and -$34.35 million in losses. Loss per share was -$0.47.

Revenue	1.66M
Gross Profit	1.52M
Operating Income	-28.88M
Pretax Income	-34.97M
Net Income	-34.35M
EBITDA	-28.66M
EBIT	-28.88M
Loss Per Share	-$0.47

Full Income Statement

Balance Sheet

The company has $20.02 million in cash and $52.47 million in debt, giving a net cash position of -$32.45 million or -$0.42 per share.

Cash & Cash Equivalents	20.02M
Total Debt	52.47M
Net Cash	-32.45M
Net Cash Per Share	-$0.42
Equity (Book Value)	-38.86M
Book Value Per Share	-0.51
Working Capital	16.48M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$24.70 million and capital expenditures -$977,000, giving a free cash flow of -$25.68 million.

Operating Cash Flow	-24.70M
Capital Expenditures	-977,000
Free Cash Flow	-25.68M
FCF Per Share	-$0.33

Full Cash Flow Statement

Margins

Gross Margin	91.05%
Operating Margin	-1,735.70%
Pretax Margin	-2,064.42%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

CLSD does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-19.41%
Shareholder Yield	-19.41%
Earnings Yield	-48.93%
FCF Yield	-36.57%

Analyst Forecast

The average price target for CLSD is $5.20, which is 472.94% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$5.20
Price Target Difference	472.94%
Analyst Consensus	Strong Buy
Analyst Count	5
Revenue Growth Forecast (5Y)	154.67%
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

CLSD has an Altman Z-Score of -21.88 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-21.88
Piotroski F-Score	2